Trial ZUMA-3

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial acronym

ZUMA-3

Full title

A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Subjects with Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL)

Description

Unknown

Primary endpoints

Secondary endpoints

EudraCT number

2015-005009-35

DRKS number

Unknown

NCT number

Unknown

ISRCTN number

Unknown

Responsible organization

Medizinische Klinik III, Telefon: 089440072551

Legal basis

Unknown

Registered by

SCHNEID-SO ()

Indications

Classification	Code	Description
ICD-10-GM	C91.0-	Akute lymphatische Leukämie [ALL]
-		Bloodcancer (leukemia, lymphoma)

In-/Exclusion (Edit)

Criterion for Inclusion

Unknown

Criterion for exclusion

Unknown

Trial design

IIT (sponsored by KUM)

Sponsor status

Unknown

Trial type

Unknown

Blinding type

Unknown

Phase

I/II

Center design

Unknown

Treatment arms count

Unknown

Sample size

Status

Recruitment active

Votes

Institutional review board - vote

Unknown

Institutional review board - reference number

PEI - vote

Unknown

PEI - reference number

BfArM - vote

Unknown

BfArM - reference number

Initiiation & lock

Date of lock (planned / actual)

Unknown / Unknown

Recruitment

Time period (from / to)

Unknown / Unknown

Therapy

Therapy line

Unknown

Therapy Category

Therapy

Tumorboards (Edit)

Additionally involved centers (Edit)

Organizational unit

	Pharmacy		Radiology
	Institut für Labormedzin		Transfusiology
	Radiotherapy		Nuclear medicine

Participants

	Function	Prename	Surname	Organization
	Principal Investigator	MARION	SUBKLEWE	Keine Organisationseinheit angegeben

Dermatology	Endocrinology	Gastrointestinal
Gynecological	Hematology	KHT
Liver	Lung	Neurooncological
Pediatry	Ortho. / Sarkoma	Urological

Public trial registry of the CCC-Munich

Trial ZUMA-3